US 9475816
Substituted-1,4-dihydropyrazolo[4,3-b]indoles
granted A61KA61K31/4162A61K31/437
Quick answer
US patent 9475816 (Substituted-1,4-dihydropyrazolo[4,3-b]indoles) held by Takeda Pharmaceutical Company Limited expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4162, A61K31/437, A61K31/4439, A61K31/496